Research Articles | Page 12 | Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
Why do we not have more drugs approved for MDS? A critical viewpoint on novel drug development in MDS Jul 2023 Blood Advances Myelodysplastic Syndromes (MDS)
Baseline and serial molecular profiling predicts outcomes with hypomethylating agents in myelodysplastic syndromes Feb 2021 Blood Advances Myelodysplastic Syndromes (MDS)
Pharmacokinetics, pharmacodynamics, efficacy, and safety of ravulizumab in pediatric paroxysmal nocturnal hemoglobinuria Jun 2024 Blood Advances Paroxysmal Nocturnal Hemoglobinuria (PNH)
Alternative donor transplantation for myelodysplastic syndromes: haploidentical relative and matched unrelated donors Feb 2021 Blood Advances Myelodysplastic Syndromes (MDS)
DNA methylation identifies genetically and prognostically distinct subtypes of myelodysplastic syndromes Oct 2019 Blood Advances Myelodysplastic Syndromes (MDS)
Guideline-based indicators for adult patients with myelodysplastic syndromes Aug 2020 Blood Advances Myelodysplastic Syndromes (MDS)
Venetoclax and Hypomethylating Agents (HMAs) Induce High Response Rates in MDS, Including Patients After HMA Therapy Failure Jul 2020 Blood Advances Myelodysplastic Syndromes (MDS)
An agenda to advance research in myelodysplastic syndromes: a TOP 10 priority list from the first international workshop in MDS Jun 2023 Blood Advances Myelodysplastic Syndromes (MDS)
A phase 3 randomized study of 5-azacitidine maintenance vs observation after transplant in high-risk AML and MDS patients Nov 2020 Blood Advances Myelodysplastic Syndromes (MDS)
Discordant pathologic diagnoses of myelodysplastic neoplasms and their implications for registries and therapies Oct 2023 Blood Advances Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS), Myeloproliferative Neoplasms (MPN)